Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Phosphodiesterase Inhibitors for Lower Urinary Tract Symptoms Consistent With Benign Prostatic Hyperplasia." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439735/0/images/ios-appstore-badge.png. Accessed 06 May 2024.
Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439735/0/images/ios-appstore-badge.png. Accessed May 6, 2024.
Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439735/0/images/ios-appstore-badge.png
Phosphodiesterase Inhibitors for Lower Urinary Tract Symptoms Consistent With Benign Prostatic Hyperplasia [Internet]. In: Cochrane Abstracts. [cited 2024 May 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439735/0/images/ios-appstore-badge.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia
ID - 439735
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439735/0/images/ios-appstore-badge.png
DB - Evidence Central
DP - Unbound Medicine
ER -